⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for eflornithine hydrochloride

Every month we try and update this database with for eflornithine hydrochloride cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory NeuroblastomaNCT03794349
High Risk Neuro...
Recurrent Neuro...
Refractory Neur...
Dinutuximab
Eflornithine Hy...
Irinotecan Hydr...
Sargramostim
Temozolomide
1 Year - Children's Oncology Group
Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory NeuroblastomaNCT03794349
High Risk Neuro...
Recurrent Neuro...
Refractory Neur...
Dinutuximab
Eflornithine Hy...
Irinotecan Hydr...
Sargramostim
Temozolomide
1 Year - Children's Oncology Group
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: